Pharmacology of labetalol in experimental animals.

[1]  R. N. Brogden,et al.  Labetalol: A Review of its Pharmacology and Therapeutic Use in Hypertension , 1978, Drugs.

[2]  R. Bellucci,et al.  Ocular hypotensive action of labetalol in rabbit and human eyes , 2004, Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie.

[3]  S. Doggrell,et al.  Release of noradrenaline by labetalol in the rat anococcygeus muscle , 1978, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  J. Anderson,et al.  Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. , 1983, The American journal of cardiology.

[5]  M. Watanabe,et al.  Qualitative and quantitative differences between the postsynaptic alpha adrenoceptors of rabbit ear artery and thoracic aorta. , 1983, Journal of Pharmacology and Experimental Therapeutics.

[6]  E. Sybertz,et al.  Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers. , 1983, Federation proceedings.

[7]  M. Cohen,et al.  Effect of labetalol and YM-09538 on neuronal uptake of (3H)norepinephrine in the rat vas deferens. , 1983, Clinical and experimental hypertension. Part A, Theory and practice.

[8]  E. Sybertz,et al.  Synthesis and comparison of some cardiovascular properties of the stereoisomers of labetalol. , 1982, Journal of medicinal chemistry.

[9]  G. P. Levy,et al.  THE α‐ AND β‐ADRENOCEPTOR BLOCKING POTENCIES OF LABETALOL AND ITS INDIVIDUAL STEREOISOMERS IN ANAESTHETIZED DOGS AND IN ISOLATED TISSUES , 1982 .

[10]  Arjun D. Sharma,et al.  Influences of labetalol a combined α- and β-adrenergic blocking agent on the dysrhythmias induced by coronary occlusion and reperfusion , 1982 .

[11]  J. Millar,et al.  Electrophysiological effects of labetolol on rabbit atrial, ventricular and Purkinje cells, in normoxia and hypoxia. , 1982, Cardiovascular research.

[12]  R. Summers,et al.  CHARACTERIZATION AND LOCALIZATION OF [3H]‐CLONIDINE BINDING IN MEMBRANES PREPARED FROM GUINEA‐PIG SPLEEN , 1982, Clinical and experimental pharmacology & physiology.

[13]  W. Louis,et al.  [3H]‐GUANFACINE: A RADIOLIGAND THAT SELECTIVELY LABELS HIGH AFFINITY α2‐ADRENOCEPTOR SITES IN HOMOGENATES OF RAT BRAIN , 1982, British journal of pharmacology.

[14]  J. Carpenter.  Intrinsic activity of labetalol on guinea‐pig isolated trachea , 1981, The Journal of pharmacy and pharmacology.

[15]  H. Y. Kwa,et al.  Identical antagonist selectivity of central and peripheral alpha 1-adrenoceptors. , 1981, Molecular pharmacology.

[16]  C. Sabin,et al.  Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927. , 1981, The Journal of pharmacology and experimental therapeutics.

[17]  R. Kloner,et al.  Reduction of myocardial ischemia by balanced alpha and beta blockade with labetalol , 1981 .

[18]  C. Sabin,et al.  Comparison of hypotensive, orthostatic and sympathetic inhibitory actions of antihypertensive drugs in rats. , 1981, Clinical and experimental hypertension.

[19]  C. P. Hsieh,et al.  DIRECT VASODILATATION BY LABETALOL IN ANAESTHETIZED DOGS , 1980, British journal of pharmacology.

[20]  F. Rengo,et al.  Protective effects of simultaneous alpha and beta adrenergic receptor blockade on myocardial cell necrosis after coronary arterial occlusion in rats. , 1980, The American journal of cardiology.

[21]  P. Devoto,et al.  Labetalol blockade of central α- and β-noradrenergic receptors in rat brain homogenates , 1980 .

[22]  O. P. Gulati,et al.  Effects of labetalol in chronic two-kidney Goldblatt hypertension (2-KGH) in rats. , 1980, Archives internationales de pharmacodynamie et de therapie.

[23]  D. Hurlbut,et al.  A novel response to propranolol: contractile response in the isolated rabbit ear artery. , 1980, Life sciences.

[24]  A. Scriabine.  Pharmacology of antihypertensive drugs , 1980 .

[25]  I. Leopold,et al.  Ocular hypotensive action of labetalol. , 1979, American journal of ophthalmology-glaucoma.

[26]  E. Whalley,et al.  β‐ADRENOCEPTOR AGONIST ACTIVITY OF LABETOLOL ON THE ISOLATED UTERUS OF THE RAT , 1979, British journal of pharmacology.

[27]  H. Robertson,et al.  A study of the relationship between cardiac β‐adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines , 1979, Clinical and experimental pharmacology & physiology.

[28]  C. Sweet,et al.  Peripheral Vasodilator and β-Adrenoceptor Blocking Properties of Several β-Adrenoceptor Antagonists , 1979 .

[29]  G. P. Levy,et al.  The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats. , 1979, Clinical and experimental hypertension.

[30]  J. Amlie.  A study of the labetalol-induced changes in conductivity and refractoriness of the dog heart in situ. , 1978, Cardiovascular Research.

[31]  G. M. Drew.  PHARMACOLOGICAL CHARACTERIZATION OF THE PRESYNAPTIC α‐ADRENOCEPTORS REGULATING CHOLINERGIC ACTIVITY IN THE GUINEA‐PIG ILEUM , 1978, British journal of pharmacology.

[32]  S. Doggrell,et al.  Effect of labetalol on the accumulation and release of noradrenaline in rat ventricle. , 1978, European journal of pharmacology.

[33]  S. Imai,et al.  Hypotensive and vascular effects of labetalol in the normotensive rat and dog. , 1978, Japanese Heart Journal.

[34]  G. P. Levy,et al.  EFFECT OF LABETALOL ON THE UPTAKE OF [3H]‐(‐)‐NORADRENALINE INTO THE ISOLATED VAS DEFERENS OF THE RAT , 1978, British journal of pharmacology.

[35]  G. Guellaen,et al.  BIOCHEMICAL EVIDENCE FOR THE DUAL ACTION OF LABETALOL ON α‐ AND β‐ADRENOCEPTORS , 1978 .

[36]  B. Prichard.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future. , 1978, British journal of clinical pharmacology.

[37]  R. Summers,et al.  THE EFFECTS OF LABETALOL (AH 5158) ON ADRENERGIC TRANSMISSION IN THE CAT SPLEEN , 1977, British journal of pharmacology.

[38]  B. Prichard.  Beta-adrenoceptor blocking drugs. , 1977, The Practitioner.

[39]  J. V. Levy.  Beta-adrenergic receptor blocking drugs in spontaneous hypertension. , 1976, The American journal of medicine.

[40]  Brittain Rt,et al.  A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug. , 1976, British journal of clinical pharmacology.

[41]  J. Catford,et al.  Carcinoma of the ampulla of Vater in a haemophiliac patient , 1976, Postgraduate medical journal.

[42]  R. Tarazi,et al.  Haemodynamic effects of propranolol in hypertension: a review. , 1976, Postgraduate medical journal.

[43]  G. P. Levy,et al.  COMBINED α‐ AND β‐ADRENOCEPTOR BLOCKING DRUG AH 5158: FURTHER STUDIES ON α‐ADRENOCEPTOR BLOCKADE IN ANAESTHETIZED ANIMALS , 1975 .

[44]  G. Maxwell.  The effects of a new α‐ and β‐adrenoceptor antagonist (AH5158) upon the general and coronary haemodynamics of intact dogs , 1973 .

[45]  J. B. Farmer,et al.  Pharmacology of AH 5158; a drug which blocks both α‐ and β‐adrenoceptors , 1972, British journal of pharmacology.

[46]  A. Barrett,et al.  Comparative chronotropic activity of β‐adrenoceptive antagonists , 1970 .